Instruction for use: Estulic

Active substance: Guanfacine

chemical name

N- (aminoiminomethyl) -2,6-dichlorobenzene (as the monohydrochloride)

Pharmacotherapeutic group:

Alpha-adrainomimetiki

Nosological classification (ICD-10)

I10 Essential (primary) hypertension

hypertension, Arterial hypertension, Arterial hypertension crisis course, Essential Hypertension, Essential hypertension, Essential hypertension, Essential hypertension, Essential hypertension, Primary hypertension, Arterial hypertension, complications of diabetes

hypertension, The sudden increase in blood pressure, Hypertensive disorders of blood circulation, hypertensive condition, hypertensive crises, hypertension, arterial Hypertension, malignant Hypertension, Hypertonic disease, hypertensive crises, Hypertensive crisis, Hypertension, accelerated hypertension, malignant hypertension, hypertensive crisis, The aggravation of hypertensive disease, Transient hypertension, Isolated systolic hypertension,

I15 Secondary hypertension

Arterial hypertension, complications of diabetes, hypertension, The sudden increase in blood pressure, Hypertensive disorders of blood circulation, hypertensive condition, hypertensive crises, hypertension, arterial Hypertension, malignant Hypertension, hypertensive crises, Hypertensive crisis, Hypertension, accelerated hypertension, malignant hypertension, hypertensive crisis, The aggravation of hypertensive disease, Transient hypertension, hypertension, Arterial hypertension, Arterial hypertension crisis course, renovascular hypertension, Hypertension symptomatic, Renal hypertension, Renovascular hypertension, renovascular hypertension, Symptomatic hypertension

Code ÀÒÕ C02AC02 Guanfacine

CompositionTablets 1 tab.

guanfacine 1 mg

(As hydrochloride guanfatsina 1.15 mg)

Other ingredients: MCC; lactose monohydrate; povidone; stearic acid

in blister 10 pcs .; In the paper cartons 2 blisters.

Pharmachologic effect
hypotensive.

Estulic Dosage and Administration

Inside, lying in bed at night (due to the sedative side effect guanfatsina). In most cases, a sufficient reduction in blood pressure is achieved with single dose of the drug at a dose of 0.5-1 mg (1 / 2-1 table.) Per day.

If necessary, the daily dose increased by 0.5-1 mg (1 / Table 1.2.) Per day at intervals usually at least 2-3 weeks to achieve the desired reduction in blood pressure. The maximum daily dose - 3 mg.

Elderly patients: Dosage adjustment is not required.

Renal impairment: a correction mode is not required.

Abnormal liver function: possible to use conventional doses because guanfatsina cumulation is not observed.

Violation of renal and hepatic function: may require dose reduction. Careful medical supervision.

Children under the age of 18 years: Safety and effectiveness have not been established.

Storage conditions of Estulic
In a dry, dark place at a temperature of 15-25 ° C.

Keep out of the reach of children.

Shelf life of Estulic
3 years.
Do not use beyond the expiration date printed on the package.
Conditions of supply of Estulic from pharmacies
On prescription.